TipRanks
Egetis Therapeutics AB (PDPHF)
FRANKFURT:PDPHF
US Market
PDPHF
Egetis Therapeutics AB
RESEARCH TOOLSreports

Egetis Therapeutics AB (PDPHF) Cash flow

2 Followers

Egetis Therapeutics AB Cash Flow

PDPHF's free cash flow for Q2 2026 was kr-95.00M. For the 2026 fiscal year, PDPHF's free cash flow was decreased by kr-40.70M and operating cash flow was kr-94.00M. See a summary of the company’s cash flow.
Cash Flow
Dec 25Dec 24Dec 23Dec 22Dec 21
Operating Cash Flow
kr -267.10Mkr -227.90Mkr -278.40Mkr -173.50Mkr -130.11M
Investing Cash Flow
kr -2.80Mkr -1.20Mkr -100.00Kkr -1.70Mkr -5.96M
Financing Cash Flow
kr 140.00Mkr 270.90Mkr 458.90Mkr 155.70Mkr -8.90M
End Cash Position
kr 215.80Mkr 351.00Mkr 303.30Mkr 127.70Mkr 143.97M
Free Cash Flow
kr -268.60Mkr -227.90Mkr -278.40Mkr -173.50Mkr -130.28M
Currency in SEK

Egetis Therapeutics AB Cash Flow